sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2016-2024

Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters &...

Home / Categories / Healthcare
Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2016-2024
Continuous Glucose Monitoring Systems Market...
Report Code
RO1/113/1366

Publish Date
01/May/2018

Pages
267
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition
3.2. Need for glucose monitoring systems

3.2.1. Diabetes-a pandemic

3.2.1.1. Type 1 diabetes
3.2.1.2. Type-2 diabetes
3.2.1.3. Prediabetes and gestational diabetes mellitus (GDM)
3.2.1.4. Gestational diabetes mellitus (GDM)
3.2.1.5. Secondary diabetes
3.2.1.6. Global healthcare expenditure on diabetes

3.3. Key Findings

3.3.1. Top investment pockets
3.3.2. Top winning strategies
3.3.3. Value Chain Analysis

3.4. Patent analysis

3.4.1. Patent analysis, by market participant
3.4.2. U.S. patent analysis, by market participant
3.4.3. Patent analysis, by year

3.5. Market Share Analysis, 2017
3.6. Government Regulations

3.6.1. FDA regulations (21CFR820)

3.6.1.1. Objective and Scope of FDA 21CFR820

3.6.2. ISO regulations (ISO 13485:2003)

3.6.2.1. Objective and Scope of ISO 13485:2003

3.7. Reimbursement Scenario
3.8. Market dynamics

3.8.1. Drivers

3.8.1.1. Benefits of CGMS over POC glucometers
3.8.1.2. Rise in incidence of diabetes cases
3.8.1.3. Technological advancements

3.8.2. Restraints

3.8.2.1. Adverse effects and accuracy
3.8.2.2. Reimbursement and stringent regulatory issues

3.8.3. Opportunities

3.8.3.1. High adoption rate of CGMS in home healthcare and ICUs
3.8.3.2. Increase in product awareness
3.8.3.3. High undiagnosed patient population

3.8.4. Impact analyses

CHAPTER 4: CONTINOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT

4.1. Overview

4.1.1. Market size and forecast

4.2. Sensors

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Transmitters & Receivers

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Integrated Insulin pumps

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS

5.1. Overview

5.1.1. Market size and forecast

5.2. Adult Population (>14 years)

5.2.1. Market size and forecast

5.3. Children Population (14 years)

5.3.1. Market size and forecast

CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Diagnostic centers/clinics

6.2.1. Market size and forecast

6.3. ICUs

6.3.1. Market size and forecast

6.4. Home Healthcare

6.4.1. Market size and forecast

CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America continuous glucose monitoring systems market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. continuous glucose monitoring systems market size and forecast, by component
7.2.2.1.2. U.S. continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.1.3. U.S. continuous glucose monitoring systems market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada continuous glucose monitoring systems market size and forecast, by component
7.2.2.2.2. Canada continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.2.3. Canada continuous glucose monitoring systems market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico continuous glucose monitoring systems market size and forecast, by component
7.2.2.3.2. Mexico continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.3.3. Mexico continuous glucose monitoring systems market size and forecast, by end user

7.2.3. North America continuous glucose monitoring systems market size and forecast, by component
7.2.4. North America continuous glucose monitoring systems market size and forecast, by demographics
7.2.5. North America continuous glucose monitoring systems market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe continuous glucose monitoring systems market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Germany continuous glucose monitoring systems market size and forecast, by component
7.3.2.1.2. Germany continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.1.3. Germany continuous glucose monitoring systems market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. France continuous glucose monitoring systems market size and forecast, by component
7.3.2.2.2. France continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.2.3. France continuous glucose monitoring systems market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. UK continuous glucose monitoring systems market size and forecast, by component
7.3.2.3.2. UK continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.3.3. UK continuous glucose monitoring systems market size and forecast, by end user

7.3.2.4. Spain

7.3.2.4.1. Spain continuous glucose monitoring systems market size and forecast, by component
7.3.2.4.2. Spain continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.4.3. Spain continuous glucose monitoring systems market size and forecast, by end user

7.3.2.5. Italy

7.3.2.5.1. Italy continuous glucose monitoring systems market size and forecast, by component
7.3.2.5.2. Italy continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.5.3. Italy continuous glucose monitoring systems market size and forecast, by end user

7.3.2.6. Netherlands

7.3.2.6.1. Netherlands continuous glucose monitoring systems market size and forecast, by component
7.3.2.6.2. Netherlands continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.6.3. Netherlands continuous glucose monitoring systems market size and forecast, by end user

7.3.2.7. Norway

7.3.2.7.1. Norway continuous glucose monitoring systems market size and forecast, by component
7.3.2.7.2. Norway continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.7.3. Norway continuous glucose monitoring systems market size and forecast, by end user

7.3.2.8. Sweden

7.3.2.8.1. Sweden continuous glucose monitoring systems market size and forecast, by component
7.3.2.8.2. Sweden continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.8.3. Sweden continuous glucose monitoring systems market size and forecast, by end user

7.3.2.9. Denmark

7.3.2.9.1. Denmark continuous glucose monitoring systems market size and forecast, by component
7.3.2.9.2. Denmark continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.9.3. Denmark continuous glucose monitoring systems market size and forecast, by end user

7.3.2.10. Finland

7.3.2.10.1. Finland continuous glucose monitoring systems market size and forecast, by component
7.3.2.10.2. Finland continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.10.3. Finland continuous glucose monitoring systems market size and forecast, by end user

7.3.2.11. Rest of Europe

7.3.2.11.1. Rest of Europe continuous glucose monitoring systems market size and forecast, by component
7.3.2.11.2. Rest of Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.11.3. Rest of Europe continuous glucose monitoring systems market size and forecast, by end user

7.3.3. Europe continuous glucose monitoring systems market size and forecast, by component
7.3.4. Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.5. Europe continuous glucose monitoring systems market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific continuous glucose monitoring systems market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan continuous glucose monitoring systems market size and forecast, by component
7.4.2.1.2. Japan continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.1.3. Japan continuous glucose monitoring systems market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. China continuous glucose monitoring systems market size and forecast, by component
7.4.2.2.2. China continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.2.3. China continuous glucose monitoring systems market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. India continuous glucose monitoring systems market size and forecast, by component
7.4.2.3.2. India continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.3.3. India continuous glucose monitoring systems market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Australia continuous glucose monitoring systems market size and forecast, by component
7.4.2.4.2. Australia continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.4.3. Australia continuous glucose monitoring systems market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea continuous glucose monitoring systems market size and forecast, by component
7.4.2.5.2. South Korea continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.5.3. South Korea continuous glucose monitoring systems market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.2.6.2. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.6.3. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user

7.4.3. Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.4. Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.5. Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA continuous glucose monitoring systems market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil continuous glucose monitoring systems market size and forecast, by component
7.5.2.1.2. Brazil continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.1.3. Brazil continuous glucose monitoring systems market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia continuous glucose monitoring systems market size and forecast, by component
7.5.2.2.2. Saudi Arabia continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.2.3. Saudi Arabia continuous glucose monitoring systems market size and forecast, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Africa continuous glucose monitoring systems market size and forecast, by component
7.5.2.3.2. South Africa continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.3.3. South Africa continuous glucose monitoring systems market size and forecast, by end user

7.5.2.4. Venezuela

7.5.2.4.1. Venezuela continuous glucose monitoring systems market size and forecast, by component
7.5.2.4.2. Venezuela continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.4.3. Venezuela continuous glucose monitoring systems market size and forecast, by end user

7.5.2.5. Argentina

7.5.2.5.1. Argentina continuous glucose monitoring systems market size and forecast, by component
7.5.2.5.2. Argentina continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.5.3. Argentina continuous glucose monitoring systems market size and forecast, by end user

7.5.2.6. Rest of LAMEA

7.5.2.6.1. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.2.6.2. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.6.3. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by end user

7.5.3. LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.4. LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.5. LAMEA continuous glucose monitoring systems market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. A. Menarini Diagnostics S.r.l.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio

8.3. DexCom, Inc.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. Echo Therapeutics, Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments

8.5. F. Hoffmann-La Roche Ltd.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. GlySens Incorporated

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.6.4. Key strategic moves and developments

8.7. Insulet Corporation

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. Johnson & Johnson

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. Medtronic Plc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. Senseonics Holdings, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com